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Abstract: The purpose of this review is to provide an overview of the current state of knowledge
regarding the experience of intimate partner violence (IPV) during pregnancy. Pregnancy IPV
is a significant problem worldwide, with rates varying significantly by country and maternal
risk factors. Pregnancy IPV is associated with adverse newborn outcomes, including low birth
weight and preterm birth. Many mechanisms for how IPV may impact birth outcomes have
been proposed and include direct health, mental health, and behavioral effects, which all may
interact. Screening for IPV during pregnancy is essential, yet due to time constraints and few
clear recommendations for assessment, many prenatal providers do not routinely inquire about
IPV, or even believe they should. More training is needed to assist health care providers in
identifying and managing pregnancy IPV, with additional research needed to inform effective
interventions to reduce the rates of pregnancy IPV and resultant outcomes.
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Intimate partner violence (IPV) is the currently accepted term used to describe what
has been referred to as “woman abuse,” “woman battering,” or “domestic violence.”
IPV has been defined as “repeated physical and/or sexual assault by an intimate partner
within the context of coercive control.”1 While this definition recognizes the role of the
intimate partner and the role of control, it excludes non-physical violence, an aspect
of IPV often overlooked by health care providers and public health professionals.2 The
US National Institutes of Mental Health Committee on Family Violence has proposed a
broader description of IPV as “acts that are physically and emotionally harmful or that
carry the potential to cause physical harm … [and] may also include sexual coercion
or assaults, physical intimidation, threats to kill or harm, restraint of normal activities
or freedom, and denial of access to resources.”3 This latter definition includes the three
primary types of IPV recognized in the literature: physical, sexual, and emotional/
psychological/verbal violence.4 Intentional use of physical force is encompassed in
“physical violence,” and use of force to compel a person to engage in a sexual act is
what is referred to as “sexual violence.”5 “Emotional,” “psychological,” or “verbal”
violence includes threats, humiliation, control of activities, isolation, name calling,
and attempts to frighten.6
The purpose of this review is to provide an overview of the current state of knowledge regarding the experience of intimate partner violence during pregnancy. It is our
hope that this paper will provide useful information for researchers, health care providers, and policy makers. Findings from research conducted in countries throughout the
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world are described including information on the prevalence
of pregnancy IPV, known effects, available screening methods, and management of this important health concern. The
research reviewed was limited to English language reports.
Preference was given to reports of large scale quantitative
studies published in peer reviewed journals. However, some
government reports were used, as were a few smaller scale and
qualitative studies. This was necessary in order to provide the
most accurate and up to date prevalence data and screening/
management recommendations, and to insure inclusion of
information about pregnancy IPV in developing countries.
As a result, however, conclusions drawn throughout this
paper reflect the subjective interpretation of the author and
the authors of other cited published papers. While a handful
of systematic reviews of the literature have been published
on various subtopics covered in this paper, a large scale
comprehensive systematic review is still needed in order to
draw specific and completely evidence-based conclusions
formulated from comparisons of level of evidence and scientific rigor across available studies.

a similar study in Spain found a 32% lifetime prevalence of
any type of IPV.26 In Ukraine, a national survey put the rate
of ever experiencing any type of IPV in a current relationship
at 20%.27 A study of women seeking medical care in Rwanda
revealed a life time prevalence of IPV at 35%,28 while similar
figures from Nicaragua range from 40% to 52%.29 Finally, a
study of women in Peru produced a lifetime IPV prevalence
rate of 45%,30 while 35% of women who participated in a
national health survey in India reported ever having experienced IPV.31 Recent findings from ten countries with data
collected using a standardized instrument revealed a physical
or sexual IPV lifetime prevalence from 15% to 71%,32 while a
review of population-based studies around the world reported
a 10%–15% lifetime physical IPV prevalence.33 Thus, it
should not be surprising that one of the outcomes from the
Fourth World Conference on Women (Beijing, 1995), was
a call to encourage additional research on violence against
women, including effective preventive measures, and an
appeal to governmental and nongovernmental agencies to
work to address IPV.34

Prevalence
General

Pregnancy

IPV is a significant medical, public health, and societal concern worldwide.7–9 Total annual health care costs related to
IPV run into the billions in the United States,10,11 and IPV
accounts for 20% of all violent crime.12 Twenty years ago,
the US Surgeon General identified IPV as a public health
problem of “epidemic” proportions.13 Reducing the rate of
violence by current and former partners is one objective
of the US Public Health Service’s Healthy People 2010
initiative.14 This is not surprising when the prevalence of IPV
is examined. The US Department of Justice estimates that
over a lifetime, 52% of women experience IPV.15 In addition, 45% of those abused also report having been forced to
have sex with their intimate partner.16 Anywhere from 1.5 to
4 million US women are victimized by an intimate partner
each year.17,18 Studies of female patients seeking health care
have reported prevalences of 19%–33% for physical or sexual
abuse,19,20 and 19%–66% for any form of IPV.17,21,22 Indeed,
IPV is the leading cause of injuries and death among US
women of childbearing age.23
Data on prevalence rates of IPV in other countries are
also available. In a 2005 national Australian population
study, 15% of women reported having experienced physical
or sexual abuse in an intimate relationship.24 A Canadian
study conducted with female family practice patients revealed
a current or recent rate of any type of IPV of 15%,25 while
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Researchers disagree about whether the prevalence of IPV
decreases during pregnancy, remains about the same, or if
a woman is at increased risk for IPV in the time between
conception and delivery. Recent comprehensive reviews
have generally concluded that while some hospital and
clinic based studies noted an increased risk, national and
international population-based studies have found either that
pregnant women are no more likely than nonpregnant women
to experience IPV, or may even be at decreased risk.35 Since
research of violence during pregnancy currently accounts for
20% of all reviewed nursing research,36 differing prevalence
estimates abound. Gazmararian et al in a comprehensive
review of the literature, concluded that the prevalence of
IPV in pregnancy ranged from 1%–20%, depending on the
way IPV is assessed and the population studied.7 Population
based studies, including the US Centers for Disease Control
and Prevention’s (CDC) Pregnant Risk Assessment Monitoring System (PRAMS), which includes tens of thousands of
women in 11 states, suggested the prevalence of pregnancy
IPV is only 2.9%–5.7%.37 Similarly, a population-based
study in New Zealand revealed a prevalence of pregnancy
IPV of 9%.38
The problem with population-based studies of IPV is that
while large and representative, the way IPV is assessed may
lead to an underestimate of those affected. For example, those
who participated in PRAMS were asked only a few general
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questions about IPV. These questions were not behaviorally
specific. In addition, the term “abused” was used, which may
be regarded as demeaning or judgmental.39 Several projects
have subsequently demonstrated that many women who claim
they have not been “abused,” on specific follow-up questioning admit to experiencing violence.40,41
Several smaller-scale studies that included behaviorally
specific questions have suggested much higher prevalence
rates of IPV during pregnancy. Two US projects that
included the Abuse Assessment Screen (AAS), a behaviorally specific measure described below, revealed a 10%
prevalence of physical abuse during pregnancy.42,43 Yet
another study of low risk women from private obstetric
practices in the US revealed 11% had experienced abuse
during pregnancy.44 A study of over 1,000 prenatal patients
at public clinics in the US revealed 15% were abused during
pregnancy,45 as did a study of nearly 1,000 women seeking care in US family practice clinics who completed the
AAS.46 Somewhat higher pregnancy IPV rates have been
reported in Nicaragua,47 Turkey,48 and Pakistan,49 while
similar or slightly lower rates have been noted in India50
and Belgium.51
Several studies have included examination of prevalence
rates of specific types of IPV. For example, 36% of patients
at an obstetrics clinic in the US reported verbal abuse, 16%
physical violence, and 14% reported severe physical violence when completing a modified AAS during pregnancy.52
And in a US study that used an even more detailed and
behaviorally specific tool (the Conflict Tactics Scale, also
described below), an incredible 81% of prenatal patients at
a family practice clinic reported some type of IPV during
pregnancy; 28% reported physical IPV, and 20% reported
sexual violence.53 These final studies highlight that prevalence disparities may in some cases be related to the type
of tool used, and whether abuse includes verbal as well as
physical abuse, and may partly explain differences in rates
reported across studies. Based on findings from research
like that presented above, some researchers have estimated
that every year in the US, over 300,000 pregnant women
experience IPV.54,55

Risk factors
As high as these rates are, the actual prevalence of IPV during
pregnancy may be even higher due to reluctance of women to
disclose IPV, especially during pregnancy.56 In addition, many
studies have indicated certain women may be at increased risk
of IPV during pregnancy due to socioeconomic status (SES),
age, marital status, or minority status. While IPV can be found

International Journal of Women’s Health 2010:2

Partner violence during pregnancy

at all SES levels, many studies identify increased risk of IPV
among both pregnant and nonpregnant lower SES women.57,58
Population based studies also confirm the link between IPV
and SES,59,60 as did analysis of the PRAMS data from pregnant
women.61 A project involving 1000+ pregnant women in the
US revealed that income and education levels were the most
significant predictors of pregnancy violence.62 Similarly, a
population-based study conducted in Chile, Egypt, India,
and the Philippines demonstrated that socioeconomic indicators were the most commonly and universally predictive
factors of IPV.63
Younger women, those who are not married, and women
from minority groups are also at increased risk for pregnancy
IPV. Many reports have identified an association between
younger age and pregnancy IPV,64,65 with those abused up
to four years younger on average.66 Some national survey
reports suggest a nearly double risk of pregnancy IPV for
women under 20.67 Similarly, single women are at increased
IPV risk during pregnancy compared with married women,66
with one study noting a fourfold increase in pregnancy IPV
risk among single versus married women.67 Other characteristics associated with increased risk include racial and ethnic
background, especially minority status.41,62,66 In the United
States in particular, Native American and African American
women have an especially increased incidence of pregnancy
IPV.68,69 These many and varied factors that are associated
with a statistically increased likelihood of pregnancy IPV
may also help explain the differing prevalence estimates
described above. Clearly, studies with samples that consist
of a large percentage of women with these “higher risk”
characteristics will produce higher prevalence estimates than
those studies with lower risk samples.
It is clear, then, that a substantial proportion of women
worldwide have been victimized by an intimate partner.
Whether pregnancy is a protective factor is unclear,
however, expectant women across various studies and
settings have reported significant levels of IPV. Rates of
pregnancy IPV appear to differ across countries, although
comparative conclusions are difficult due to differences in
study methodologies. However, we know that many more
women will report abuse when questions about psychological victimization are included. Additionally, we know that
while no groups of women can be considered immune from
pregnancy IPV, certain characteristics are associated with an
increased likelihood of this experience, and disproportionate inclusion of higher risk women in studies will increase
reported prevalence rates. In particular, younger minority
women at the lower socioeconomic levels and who are
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unmarried are more likely than other women to experience
IPV while pregnant.

Effects
Low birth weight and preterm delivery
The experience of IPV during pregnancy is associated with
numerous negative consequences, including decreased infant
birth weight and increased rates of prematurity. Low birth
weight (LBW) and preterm births are leading causes of neonatal morbidity and mortality. Babies born before 37 completed weeks gestation are classified as preterm, while infants
born weighing , 2,500 g are termed LBW. Prematurity and
LBW often coexist, however 40% of all LBW babies are born
at 37 weeks or later.70 These full term babies are referred to
as small-for-gestational-age (SGA). Premature and low birth
weight infants consume disproportionate amounts of scarce
health care resources, and for those babies who survive prematurity and low birth weight, adverse initial and long-term
outcomes are common. In fact, an infant’s gestational age
(GA) and birth weight at delivery are the strongest biological predictors of immediate and long-term developmental
outcomes.71 Research documents the long-term sequelae
of extremely premature and LBW infants. Such children
commonly have cognitive deficits, motor delays including
cerebral palsy, academic difficulties, language delays, and
significantly increased rates of attention problems, behavioral
difficulties, and psychological problems.72–74 But even children born at 32–36 weeks, or weighing 1,500–2,500 g, are
at increased risk.75 Cognitive deficits, including neurological
impairment,76 delayed mental development and decreased
IQ,77–79 memory problems,80 and increased need for special
education services81 are common. Attention, behavior, and
psychological problems have also been linked to prematurity, LBW, and SGA.79,82 Still other risks for preterm and
LBW births are physical/biological, as several studies have
documented permanent growth restriction for children born
prematurely or with LBW.79,83 Further, poor general health
well into childhood has been associated with SGA birth.84
Specific health risks including an increased risk of sudden
infant death syndrome,85,86 and increased severity of respiratory synctial virus (RSV) infection for premature infants
have been noted.87,88
It is apparent, then, that many and varied adverse outcomes are associated with prematurity and LBW. Thus, that
IPV during pregnancy might be linked to prematurity and
LBW births is of great concern. Indeed, given such an association, it may be possible to reduce LBW and prematurity
rates through interventions targeting IPV.89 Dozens of studies
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have now been published that included an examination of
the relationship between IPV and prematurity and LBW.
Generalizations across studies are difficult due to different populations, assessments, methods, and data analysis.
However, over a dozen recent studies have identified significant associations. An analysis of the US PRAMS data
revealed a significant link between physical abuse during
pregnancy and LBW.61 Reports of two other smaller scale
studies also include significant associations between physical IPV during pregnancy and low birth weight,90,91 with one
including a mean difference in birth weight of 164 g.90 And
in another study, compared with non-abused women, those
abused had significantly increased rates of preterm deliveries
(22% vs 9%) and LBW babies (16% vs 6%).92 Research with
women in China, South Africa, and Saudi Arabia revealed
similar findings.93–95
Still other studies found signif icant associations
between pregnancy IPV and newborn outcomes, even
after control for background and other factors associated
with either IPV and/or newborn outcomes. For example,
among over 400 low income women, any form of IPV
during pregnancy was associated with a 250 g decrease
in infant birth weight, and this link remained significant
even after control for sociodemographic factors including prenatal care and stressors.96 Similarly, other studies
have noted a two- to fourfold increase in the risk of LBW
associated with pregnancy IPV after control for confounding.58,97 Using police reported, rather than self-reported
IPV, significant negative associations between IPV and
birth weight and gestational age at delivery were identified, even after control for sociodemographic f actors,
adequacy of prenatal care utilization, and prenatal smoking.98 A recent large-scale study revealed that physical
injury due to IPV was associated with preterm birth and
a 75 g reduction in birth weight, even after control for
sociodemographics, prenatal substance use, pregnancy
weight gain, and pregnancy complications.19 Interestingly,
the authors report that when gestational age is controlled,
the birth weight reduction is only 24 g, suggesting that
most of the association between IPV and birthweight can
be explained by a decrease in gestational age. Finally, a
meta-analysis of eight methodologically sound and recent
studies revealed a significant association between pregnancy IPV of any kind and newborn outcomes (pooled
odds ratio of 1.4 for birth weight). The authors of this
review concluded that due to the recent findings from
analyses that included control for a multitude of factors,
a relationship between IPV and newborn outcomes indeed
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exists, but may be secondary to, or explained by, prenatal
smoking, substance use, or inadequate pregnancy weight
gain among other factors.89

Mechanisms for effects
So why might the experience of IPV lead to poor birth outcomes? Many factors may explain the association including
direct physical effects, and the impact on mental health and
behavioral changes. For example, abuse involving abdominal
trauma can lead to premature labor, rupture of membranes,
placental abruption, and ruptured uterus, all of which lead
to preterm birth or even fetal demise.99–102 IPV has also been
associated with an increased incidence of urinary tract infections which have been associated with preterm birth.103–105
Additionally, IPV during pregnancy may exacerbate chronic
problems such as hypertension and gestational diabetes, both
of which have implications for newborn outcomes.103,106 And
finally, cervical and uterine infections, including HIV and
other sexually transmitted diseases (STDs), occur at higher
rates among abused pregnant women compared to those not
abused,66,107 placing them at increased risk for intrauterine
growth restriction and preterm birth.108–110
In addition to direct physical and health effects, pregnancy
IPV has been associated with many mental health factors
as well.111,112 Women who experience IPV either during or
outside of pregnancy were found to have a ninefold increase
in risk for a mood or anxiety disorder,113 to be significantly
more likely to be hospitalized for mental health related
problems,98 and half of the women referred to a rural mental
health center by their health care provider turned out to be
unrecognized battered women.114 Experience of mental health
problems during pregnancy has in turn been associated with
adverse newborn outcomes.115 Depression has been identified
as the most common mental health consequence of IPV,116
with nearly 40% of abused women reporting symptoms,117,118
and depression in pregnancy has been linked to both preterm
birth and LBW.119–121 In addition, other studies have shown that
45% of women experiencing IPV were found to have posttraumatic stress disorder,118 with stress in pregnancy associated
with both preterm birth and LBW in multiple projects.122–124
These findings have led researchers to conclude that further
work is needed to understand the role of depression and stress
in the relation between IPV and preterm and low birth weight
births,125,126 so that clinical practice might be better informed
and appropriate interventions can be designed.127
Besides the effects IPV may have on physical or mental
health, IPV has also been associated with many negative
health behaviors during pregnancy, perhaps stemming at least
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in part from the associated mental health effects as described
above. These behaviors, including inadequate prenatal care
utilization, inadequate weight gain, and smoking, drinking, and substance use during pregnancy, have in turn been
associated with negative newborn outcomes. For example,
one of the primary health behavior factors associated with
both IPV and prematurity and LBW is inadequate prenatal
care utilization. A link between IPV and late entry into
prenatal care has been described in multiple reports,91,107,128
with those experiencing IPV twice as likely to begin care
in the third trimester,65,129 and entering care up to 6.5 weeks
later,130 compared with other women. Additionally, women
experiencing pregnancy IPV are significantly more likely
than non-abused women to miss three or more prenatal visits
(45% vs 28%).44
Much published research suggests inadequate prenatal
care utilization is linked to poor neonatal outcomes.131
In particular, studies involving higher risk populations
(minorities, teenagers, lower SES) have revealed significant
relations between prenatal care (timing of entry, number of
visits, and adequacy of care utilization) and both infant birth
weight and prematurity.132–135 Even in low risk populations,
a link between prenatal care rates and prematurity136 and
LBW137 has been noted.
Poor nutritional intake and inadequate weight gain have
also been associated with both pregnancy IPV and adverse
newborn outcomes. Several reports detail an association
between pregnancy IPV and failure to gain weight.97,138 In fact,
one study noted that history of physical IPV increases the risk
of inadequate prenatal weight gain threefold.139 Additionally,
many studies have identified an association between inadequate pregnancy weight gain or poor nutrition and adverse
outcomes, including LBW.140–142 A recent study found that
the relation between pregnancy IPV and infant birth weight
was completely mediated by poor pregnancy weight gain,143
and others have supported this contention.144
Smoking during pregnancy is another health factor
linked to both IPV and newborn outcomes. Many studies
have described an association between IPV and pregnancy
smoking.45,66,107,138,145 Projects have reported that smoking partially mediates the association between IPV and poor newborn
outcomes,143 possibly due to the association between smoking
and stress and depression.115,126,143 As had been reviewed,146,147
prenatal cigarette exposure is associated with both LBW and
prematurity. Dozens of studies have reported a link between
prenatal cigarette exposure, and prematurity/LBW.148–151
Effects are not limited to those heavily exposed. National
statistics for 2002 reveal that 11.5% of babies born to light
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smokers (fewer than six cigarettes/day) were LBW, more than
50% higher than the LBW rate for births to nonsmokers.145
Finally, alcohol and illicit substance use have also been
implicated in the relationship between IPV and adverse
newborn outcomes. Multiple projects have described an
increased risk of alcohol and substance use among pregnant
battered women.44,98,125,143 Indeed, up to 50% of alcoholism
in women may be precipitated by abuse.152 Numerous studies have identified an association between prenatal alcohol
and drug exposure and adverse newborn outcomes including
prematurity and low birth weight.92,121,148,153–155
Clearly, the experience of IPV during pregnancy has
many adverse consequences. Babies born to women who
are subjected to IPV while pregnant have a significantly
increased risk of being born preterm or LBW, which can
result in immediate and long term health and developmental
problems. Effects are not limited to women who experience
only physical abuse or trauma, as even psychological IPV
has been linked to poor pregnancy outcomes. Many maternal
factors are associated with pregnancy IPV, including physical
and mental health problems, and negative health behaviors.
Causality has not been established, and thus the direction
of these relationships is not known. However, knowledge
of the maternal characteristics statistically associated with
pregnancy IPV can provide useful information to clinicians
attempting to identify women experiencing or risk for experiencing IPV. Again, while any woman could be a potential
victim, those most likely to be experiencing pregnancy IPV
are women with recurrent pregnancy infections, including
STDs, women who suffer from depression or anxiety, women
with inadequate prenatal care utilization, those who fail to
gain adequate weight, and women who smoke, consume
alcohol, or use illicit substances during pregnancy. Knowledge of these characteristics and related demographic factors
described in the previous section, together with the use of
validated IPV assessment tools described in the subsequent
section, can aid health care providers in the identification of
women most at risk for IPV.

Screening and management
Many professionals and organizations have addressed IPV by
recommending universal screening and promoting zero tolerance for IPV. Nearly two decades ago, the American Medical
Association recommended screening all women presenting to
primary care and many secondary care specialties.156 Similar recommendations have been advanced by the American
Academy of Family Physicians,157 the American College
of Nurse-Midwives (ACNM),158 the Joint Commission on
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Accreditation of Health Care Organizations,159 and the World
Health Organization.160 The American College of Obstetricians and Gynecologists (ACOG) has recommended that
women be screened for IPV routinely at preconception,
family planning, and gynecologic visits, as well as at the first
prenatal visit, at least once per trimester, and at post partum
checkup.161 Reinforcing their commitment to addressing
IPV, ACOG sent material to all 28,000 members about IPV,
including signs of abuse.162 ACOG and ACNM have been
particularly proactive, as pregnancy may be the only time a
woman will regularly access health care.128,163,164 In addition
to the position statements of the professional organizations,
based on the findings of their own and other studies, many
researchers and clinicians have also advocated for universal
IPV screening in health care settings.44,127,145,165

Screening attitudes and practices
Despite the recommendations, screening for IPV in health
care settings in general, and during pregnancy in particular,
is far from universal. Studies vary widely in findings related
to whether providers believe they should screen and whether
they actually do screen female patients for IPV. For example,
a US survey of primary care resident physicians revealed that
95% thought screening for IPV was ‘important.’166 A survey
of Scottish midwives found only 66% thought they should
ask patients about IPV,167 while a study involving obstetricians in Pakistan found just under half felt women should be
routinely screened for IPV.168 Additionally, a British study
revealed that only 15% of general practitioners and practice
nurses felt they should be routinely asking about IPV.169
In a survey of over 300 primary care physicians in the US,
only 6.2% reported screening for IPV at initial visits, and
only 7.5% did at annual exams.170 In other studies, anywhere
from 10%–65% of US physicians report following ACOG
screening guidelines for IPV during pregnancy.171–173 A study
in Belgium revealed only 8% of gynecologists routinely
screened for IPV,167 while in a Canadian study, 42% of physicians reported routinely screening for IPV.174 Unfortunately,
surveys of patients themselves often result in even lower
screening prevalence estimates. In two separate samples,
only 6%175 and 18%176 of women recalled having been asked
about IPV by their physician. This disconnect between what
physicians say they do and what patients remember being
asked was especially evident in a survey of physicians and
their female patients, where 33% of physicians said they
screen for IPV, while only 7% of their patients recall being
asked about IPV.177 These and similar findings led the authors
of a comprehensive review to conclude that the majority
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of health care providers do not find a universal screening
program for IPV acceptable or practical, with acceptance
rates ranging from 15%–95% across studies worldwide.178
They did note, however, that acceptability of IPV screening
was generally higher in the US than in other countries examined. Finally, because of these widely varying prevalence
rates of acceptance and practice related to IPV screening,
the CDC concluded in 2004 that the extent to which US clinicians incorporate screening for IPV into their practices is
relatively unknown.179 A comprehensive review on studies in
dozens of countries reached a similar conclusion with respect
to screening practice rates in other countries.178
Additional research has been conducted to investigate
why, despite national policies and recommendations, health
care providers are not screening all of their female patients,
and pregnant women in particular, for IPV. Failure to screen
is unfortunate, as a recent study revealed disclosure of IPV to
increase from 5% to 30% after implementation of universal
screening.180 Others have reported that when asked directly
about IPV, most women will answer honestly if separated
from their batterers.181 Multiple reasons for failure to screen
have been advanced, including general provider unwillingness
as described above. However, the most common barrier to
IPV screening in health care settings appears to be time,182,183
with as many as 46% of providers citing time constraints as
the primary reason for not screening all female patients for
IPV.184 Other reasons offered for failure to routinely screen
for IPV include lack of confidence and personal discomfort,
belief that women will not disclose abuse or seek help, and
not knowing what to do if IPV is revealed.178 Additionally,
most providers cite a lack of knowledge in IPV assessment.
Indeed, in a recent US survey, 96% of physicians believed that
training in domestic violence screening should be included in
medical education,185 while a recent study in Belgium revealed
that fewer than 7% of gynecologists had ever received any
education or training in IPV assessment.186
Unfortunately, even when health care providers do inquire
about IPV, some women still do not disclose their experiences.
A Canadian study found that only 29% of women who experienced IPV have discussed it with their health care provider.187
Reasons for failure to disclose have been summarized in
multiple papers and include fear of retaliation, being blamed,
that others won’t understand, lack of confidentiality, losing
their children, losing what little control they have, economic
or psychological dependence on the abuser, and the promise
of change.39,188 Despite this, certain circumstances increase
the likelihood that women will disclose IPV to their health
care providers including direct, repeated, and behaviorally
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specific questioning.7,20,21,173 As discussed previously, asking
questions about specific behaviors, and avoiding terms such
as “abuse” are key to accurate disclosure. For example, after
being asked if they had been abused by their partner, 38% of
women changed their answer from no to yes when follow-up
questioning was behaviorally specific.116 In general, both
abused and non-abused women don’t mind being asked,
and in fact agree and expect that providers should screen
women for IPV.189–192 In one study, 96% of a sample of over
1,300 women asked prenatally felt ‘OK’ about being asked,192
and in another study, it was actually the abused women who
were 1.5 times more likely than those not abused to agree
with universal screening.193 A recent comprehensive review
on the topic concluded that most women found IPV screening
in a health care setting acceptable, provided the health care
professional was sensitive, nonjudgmental, and they did not
feel the information revealed would be used to show they
were not caring for their children properly.178 All of these
findings have led researchers to conclude that if the impact
of IPV is ever to be reduced, it is imperative that health care
professionals routinely screen all women for IPV.4,143,163

Screening tools
Many health care provider attempts to screen for IPV involve
asking only one question. Unfortunately, recent research has
suggested that responses to single IPV items do not correspond to scores on longer, standardized measures.194 In fact,
in one study of prenatal patients, single item responses were
completely unrelated to both verbal aggression (r = 0.03)
and violence (r = −0.05) scales of the well validated Conflict Tactics Scale (CTS).195 The CTS,196 and the more recent
modification the CTS2,197 have long been regarded as the gold
standard of IPV assessment,198 and take 10–15 minutes to
complete. While the original CTS2 asks questions about IPV
based on occurrences in the past year, the authors permit use
of other referent periods,197 and pregnancy studies typically
ask about occurrences in the 12 months before pregnancy,
and separately for occurrences since the beginning of pregnancy.145 Other IPV tools of similar length include the Index
of Spouse Abuse,199 the Severity of Violence Against Women
Scale,200 and the Abuse Risk Inventory.201
Due to the length of the CTS2 and other tools listed
above, and the fact noted that providers often fail to screen
due to time constraints, these tools are not practical for
use in clinical settings. Even short versions contain, at a
minimum, 24 items.197 Thus, many shorter IPV measures
more appropriate for clinical use have been developed in
the last two decades. The CDC have recently developed a
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compendium of brief partner violence assessment tools that
are recommended for use in health care settings.202 This
publication includes dozens of tools, including information
about their administration and psychometric properties, and
is an excellent provider resource. Some of the more commonly used tools are described here. The five-item AAS,203
is a commonly used IPV screen due to ease of administration
and established reliability and validity.35 The AAS is most
sensitive to major physical violence, but is less accurate in
identifying women who have experienced minor physical
or emotional abuse.178 In addition to the AAS, several other
measures that screen for IPV are available. The seven-item
Woman Abuse Screening Tool (WAST)204 was specifically
designed for use in family practice settings to identify female
patients experiencing emotional and/or physical abuse by
their intimate partner (Appendix 1). While comprehensive for
a screening tool, cut-points for determination of abuse have
not been well validated.178 A similar measure, the four-item
HITS,205 was designed by a focus group of family physicians
for use in outpatient clinical settings (Appendix 2). HITS is
an acronym, representing the four questions asking about
“Hits,” “Insults,” “Threatens,” and “Screams,” making it
easier for providers to remember. Questions are answered
on a five-point scale, with a cut-off of 10.5 maximizing both
sensitivity and specificity.178 In contrast to the AAS and HITS,
which assess how much and to what degree IPV is occurring,
the 15-item Danger Assessment scale (DA)116 measures risk
of extreme consequences of IPV.
The US Preventive Service Task Force has concluded
that there is still insufficient evidence to recommend one
IPV screening tool over another.159 While further research is
needed to determine the most appropriate and effective way
to assess IPV in clinical settings,206 some comparative findings have been published. A recent study of women’s preferences for IPV screening revealed the WAST to be preferable
over other standardized tools.192 While acceptability of a tool
to patients will likely increase disclosure, such data do not
tell us about the reliability and validity of various screening tools. Feder and colleagues conducted a comprehensive
review of dozens of studies from across the world, many of
which involved comparisons of various screening tools to
gold standards such as the CTS.178 They concluded that the
HITS screening tool demonstrates the best predictive power,
validity, and reliability, and is also the easiest for providers
to remember. However, this tool does not ask about sexual
abuse or ongoing violence, and thus may need to be combined with another screening tool. They review authors also
concluded that the WAST and AAS perform almost as well
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as the HITS in health care settings. Thus, it appears that any
of these three tools could be effectively used by prenatal care
providers to screen for IPV in their patients.

Management and intervention
While we are beginning to learn about the best way to screen
for IPV during pregnancy, much less is known about how to
effectively manage this problem once it is identified. Indeed,
as described above, many providers do not routinely screen
for IPV because they do not know what they should do if it
is discovered. This is unfortunate as studies have revealed
that disclosure of abuse in a health care setting, even in the
absence of a subsequent intervention, can reduce the incidence of additional violence.207 A recent survey of US physicians, with obstetricians the largest specialty group included,
examined attitudes about managing IPV in patients.208 Most
responders (85%) felt the work was significant, although
few (11%) had overall positive feelings about it. Most felt
helping IPV victims was stressful, difficult, and risky. Additionally, the majority of respondents reported no or minimal
training in addressing IPV with patients, and the majority
scored below 80% on an IPV knowledge test. The study
authors concluded that health care workers need additional
training and support in order to effectively manage patients
experiencing IPV.
Several options are available to health care providers in
the management of patients, and pregnant women in particular, who are being abused. The first type is interventions for
the women themselves. Health care providers with training
in this area may be able to provide limited counseling in the
form of a brief intervention or motivational interviewing.
However, lack of time and experience precludes this option in
the vast majority of cases. Other more commonly employed
options are referrals to safe environments, including family
members or shelters, referrals to counseling or other community based resources, and the provision of resource information. Another set of intervention options is referral of the
perpetrator to a batterer treatment program. The practicality
of this approach is somewhat limited, however, if the provider
has no contact with the abuser or the abuser is unwilling to
seek help. However, along these lines, a woman who is being
physically abused can be encouraged to file legal charges or
seek a protective order.
Unfortunately, few published studies provide data to
demonstrate the effectiveness of any of the above management options. One exception is a report on a US intervention
project involving six telephone calls from a nurse over an
eight-week period in which safety-promoting behaviors were
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discussed.209 Compared to controls, women who received the
phone calls engaged in significantly more safety-promoting
behaviors at follow-up. A handful of reports can be found on
projects outside the US and Europe. One is an initial report on
an IPV intervention implemented in Australia which focused
on the provision of a community mentor to provide assistance,
support, and advocacy.210 While preliminary data suggest
this approach is somewhat effective, final data are not yet
available. A second report is from a study in Nicaragua with
an intervention focused simply on inquiring about possible
IPV discussing attitudes toward it.47 While the majority of
women reported that their abuse had ended at follow-up, no
control group was used in this study, limiting the usefulness
of the findings.
Two recent reviews have attempted to synthesize what
we know about the effectiveness of treatment options
in North America and Europe for women experiencing
IPV. The first was conducted by Wathen and MacMillan,
published in 2003.211 They reviewed management options
for both the victim and the abuser. In terms of studies on
interventions for women, most involved examining the
effectiveness of shelter stays, advocacy counseling, personal
and vocational counseling, and enhanced prenatal counseling addressing IPV. The highest quality rating of any of the
studies was “fair,” indicating that outcomes were based on
self-report and/or tools used were of uncertain validity.
While all studies reviewed had methodological weaknesses,
some conclusions could be drawn. First, no current evidence
of suitable quality exists to evaluate the effectiveness of a
shelter stay to decrease the incidence of violence. While
this does not mean that a shelter stay may not be useful
for some abused women, further research is needed to
more definitely evaluate the effectiveness of this option.
However, there was fair evidence to suggest that a shelter
stay combined with advocacy counseling can decrease the
rate of re-abuse and improve quality of life over the next
two years.211 Thus, it appears that health care providers may
be able to effectively manage IPV in their female patients,
and pregnant patients in particular, by becoming aware
of both shelter and advocacy programs in their area, and
encouraging patients they identify as experiencing IPV to
use these services.
The Wathen and MacMillan review211 also examined
studies that targeted male batterers, either alone or with their
partners. These interventions have been more thoroughly
studied, and thus evidence about their effectiveness is more
readily available. Unfortunately, most programs that work
with abusers to decrease the incidence of IPV have not been
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shown to be effective. In contrast, there is some evidence to
suggest that arrest of the perpetrator, and the use of protective orders, can be effective in some cases. However, there is
also data demonstrating that in some cases this approach can
actually lead to an escalation of violence, especially when
the perpetrator is unemployed or otherwise has little to lose
by not complying with the legal system. Finally, initial data
suggest that protection orders combined with legal advocacy
and counseling may reduce the incidence of re-perpetration
for many men. Thus, health care providers can also help to
manage IPV in patients by having information available
about the legal system and local options for assistance for
batterers.
A more recent Cochrane review, conducted by Ramsay
and colleagues,212 specifically examined the effectiveness of
IPV interventions for women that involved advocacy. Ten
studies were found that met inclusion criteria, and all differed in type and intensity of advocacy, outcomes assessed,
and duration of follow-up. Overall, they found that intensive
advocacy (12 hours or more total) as part of or after a shelter
stay improved quality of life at up to 12 months follow-up,
and increased the chances of termination of physical abuse
at up to 24 months follow up. Intensive advocacy was not
found to impact either depression or psychological distress.
Minimal data were available to definitively evaluate the
effectiveness of brief advocacy interventions, but evidence
suggests they do increase the use of safety behaviors both
short and long term, even for women who remain with the
perpetrator. However, the authors conclude that while intensive advocacy is likely to be most effective, further research
is needed to determine the utility of briefer advocacy interventions, both for women who leave or who remain with the
perpetrating partner.212

Conclusion
It is clear that pregnancy IPV is a significant problem worldwide and is associated with adverse newborn outcomes. Many
mechanisms for how IPV may impact LBW and preterm
births have been proposed and include direct health, mental
health, and behavioral effects, all of which may help providers
identify women most at risk. Screening for IPV during pregnancy is essential, yet due to time constraints and few clear
recommendations for assessment, many prenatal providers
do not routinely inquire about IPV. More training is needed
to assist health care providers in identifying and managing
pregnancy IPV, with additional research needed to inform
effective interventions to reduce the rates of pregnancy IPV
and resultant outcomes.
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Appendix 1
Woman Abuse Screening Tool (WAST)
from Brown and Ryan204

Appendix 2
HITS Scale: Hurts, Insults, Threatens,
Screams from Sherin et al205

1. In general, how would you describe your relationship?
A lot of tension (2) Some tension (1)
No tension (0)
2. Do you and your partner work out arguments with…
Great Difficulty (2)
Some Difficulty (1)
No difficulty (0)
3. Do arguments ever result in you feeling put down or bad
about yourself?
Often (2)
Sometimes (1) Never (0)
4. Do arguments ever result in hitting, kicking, or
pushing?
Often (2)
Sometimes (1) Never (0)
5. Do you ever feel frightened by what your partner says or
does?
Often (2)
Sometimes (1) Never (0)
6. Has your partner ever abused you physically?
Often (2)
Sometimes (1) Never (0)
7. Has your partner ever abused you emotionally?
Often (2)
Sometimes (1) Never (0)

Please respond to the questions below using the following
scale:
1 = Never
2 = Rarely
3 = Sometimes
4 = Fairly often
5 = Frequently
Since you were pregnant, has a partner or ex-partner…
_____ 1. Physically hurt you?
_____ 2. Insulted you fairly often?
_____ 3. Threatened you?
_____ 4. Screamed at you fairly often?
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